Formulation and in vitro/in vivo evaluation of buccal bioadhesive captopril tablets

S.T.P. Pharma Sciences

Volumn 8, Issue 6, 1998, Pages 357-363

  Yaziksiz Iscan Y ^a   Capan Y ^a   Senel S ^a   Sahin M F ^b   Kes, S ^a   Duchene D ^c   Hincal, A A ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c UNIV PARIS SUD   (France)

Author keywords

Bioadhesion; Buccal absorption; Buccal bioadhesive tablet; Captopril; Interpolymer complex

Indexed keywords

CAPTOPRIL; CARBOMER; EUDRAGIT; EUDRAGIT RS PM; HYDROXYPROPYLMETHYLCELLULOSE; KAPRIL; UNCLASSIFIED DRUG;

ADHESION; ADULT; ANIMAL TISSUE; ARTICLE; CATTLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG RELEASE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOUTH MUCOSA; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TABLET FORMULATION;

EID: 0032418482     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. AL-FURAIH T., McELNAY J.S., NICHOLLS D.P., SCOTT M.G. and STANFORD C.F. - Influence of pH on the buccal absorption of captopril. - Proc. British Pharmaceutical Society, 6 to 8 July 1988, pp. 656P-657P.
2. TSCHOLLAR W. and BELZ G.G. - Sublingual captopril in hypertensive crisis. - Lancet, 2, 34-35, 1985.
3. TSCHOLLAR W., BELZ G.G., ESSIG J., RUNGE J. and WELLSTEIN A. - Fast and safe blood pressure reduction from sublingual captopril. - J. Am. Coll. Cardiol., 9 (suppl. 2), 226A, 1987.
4. AL-FURAIH T.A., McELNAY J.C., ELBORN J.S., RUSK R., SCOTT M.G., McMAHON J. and NICHOLLS D.P. - Sublingual captopril: a pharmacokinetic and pharmacodynamic evaluation. Eur. J. Clin. Pharmacol., 40, 393-398, 1991.
5. ISHIDA M., MACHIDA Y., NAMBU N. and NAGAI T. - New mucosal dosage form of insulin. - Chem. Pharm. Bull., 29, 810-816, 1981.
6. PONCHEL G. - Formulation of oral mucosal drug delivery systems for the systemic delivery of bioactive materials. - Adv Drug Del. Rev., 13, 75-87, 1994.
7. ANLAR S., ÇAPAN, Y., GÜVEN, O., GÖGÜS A., DALKARA T. and HINCAL A.A. - Formulation and in vitro/in vivo evaluation of buccoadhesive morphine sulphate tablets. - Pharm. Res., 11, 231-236, 1994.
8. TAYLAN B., ÇAPAN Y., GÜVEN O., KES S. and HINCAL A.A. -Design and evaluation of sustained-release and buccoadhesive propranolol hydrochloride tablets. - J. Control. Rel., 38, 11-20, 1996.
9. SATOH K., TAKAYAMA K., MACHIDA Y., SUZUKI Y., NAKAGAKI M. and NAGAI T. - Factors affecting the bioadhesive property of tablets consisting of hydroxypropyl cellulose and carboxyvinyl polymer. - Chem. Pharm. Bull., 37, 1366-1368, 1989.
10. PONCHEL G., TOUCHARD F., WOUESSIDJEWE D., DUCHENE D. and PEPPAS N.A. - Bioadhesive analysis of controlled release systems. III: Bioadhesive and release behaviour of metronidazole containing poly (acrylic acid)-hydroxypropyl methyl cellulose systems. - Int. J. Pharm., 38, 65-70, 1987.
11. KLEIN J., COLIN P., SCHERER E., LEVY M. and KOREN G. -Simple measurement of captopril in plasma by high-performance liquid chromatography with ultraviolet detection. - Ther. Drug Monitor., 12, 105-110, 1990.
12. KAWAHARA Y., HISAOKA M., YAMAZAKI Y., INAGE A. and MORIOKA T. - Determination of captopril in blood and urine by high-performance liquid chromatography. - Chem. Pharm. Bull., 29, 150-157, 1987.
13. BUDVARIS. (Ed.).-The Merck Index, 11th Ed., Merck Co., Inc., Rahway, United States.
14. TAKAYAMA K., HIRATA M., MACHIDA Y., MASADA T., SANNAN T. and NAGAI T. - Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. - Chem. Pharm. Bull., 38, 1993-1997, 1990.
15. PEPPAS N.A. - Analysis of Fickian and non-Fickian drug release from polymers. - Pharm. Acta Helv., 60, 110-111, 1985.
16. VIGOREAUX V. and GHALY E.S. - Fickian and relaxational contribution quantification of drug release in a swellable hydrophillic polymer matrix. - Drug Dev. Ind. Pharm., 20, 2519-2526, 1994.
17. SENEL S., ÇAPAN Y., SARGON M.F., IKINCI G., SOLPAN D., GÜVEN O., BODDE H.E. and HINCAL A.A. - Enhancement of transbuccal permeation of morphine sulfate by sodium glycodeoxycholate in vitro. - J. Control. Rel., 45, 153-162, 1997.
18. McELNAY J.C., AL-FURAIH T.A., HUGHES C.M., SCOTT M.G., ELBORN J.S. and NICHOLLS D.P. - The effect of pH on buccal and sublingual absorption of captopril. - Eur. J. Clin. Pharmacol., 48, 373-379, 1995.
19. DUCHIN K.L., SINGHVI S.M., WILLARD D.A., MIGDALOF B.H. and McKINSTRY D.N.-Captopril kinetics.-Clin. Pharmacol. Ther., 31, 452-458, 1982.
20. KRIPALANI K.J., McKINSTRY D.N., SINGHVI S.M., WILLARD D.A. and VUKOVICH D.A. - Disposition of captopril in normal subjects. - Clin. Pharmacol. Ther., 27, 636-641, 1980.
21. HO H., WANG H., SHEU M. - The evaluation of granulated excipients as matrix material for controlled delivery of captopril. -J. Control. Rel., 49, 243-251, 1997.
22. ONAYAMA K., HIRAKATA H., ISEKI K., FUJIMI S. and OMAE T. - Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure. - Hypertension, 3, 456-459, 1981.